• EAACI
  • Events
  • Professionals
  • Patients
  • News
Become a Member
Become a Member

EAACI Congress 2024 Back

31 May - 03 June 2024 Valencia, Spain

Lawrence DuBuske

United States of America

Lawrence DuBuske

Lawrence DuBuske MD has served as Clinical Professor of Medicine, George Washington University School of Medicine, Washington, DC (2010) and Affiliate Physician, The George Washington University Hospital, Washington, DC; and Director of Immunology Research Institute of New England (1989)





Sessions

Friday 31 May
Сytokine profiles in patients with allergic rhinitis during allergen-specific immunotherapy with and without added vitamin D
The PAF inhibitor Rupatadine has a positive influence on clinical and laboratory findings in patients with urticarial vasculitis
Increases in expression of HIF1A signaling pathway microRNAs impact regulation of immunity after xenon inhalation
Impact on mesothelin levels of a probiotic diet in women with endometriosis induced infertility
Immune impact of tolerogenic dendritic cells in patients with type 1 diabetes
A method for generation of mast cells from human umbilical cord hematopoietic stem cells
Impact of reaction conditions on surface modification of glass microtiter wells used in development of allergen microarrays
Development of a new method to generate transduced dendritic cells expressing MART-1 antigen by employing Lentivirus vectors
Modelling of atomistic 3D-structures of Cis- and Trans- HVEM-BTLA complexes
Аnti-inflammatory effect of extracorporeal shock wave therapy as treatment for chronic calculous prostatitis
Suboptimal adherence to vaccination protocols among physicians and other medical professionals in Ukraine
Saturday 1 Jun
Sensitization patterns of pollen allergic patients in the Republic of Belarus
Patients with allergic rhino-conjunctivitis have a pro-inflammatory serum cytokine profile
Detoxification using a specialized diet results in immunomodulatory, anti-inflammatory and antioxidant effects in patients with COVID 19 and various malignancies
Effect of the C-589T IL-4 gene SNP on risk of COVID-19 infection
Assessment of the impact of С-174G IL-6 gene SNPs in COVID 19 patients
Assessment of the impact of the G-1082A SNP of the TNFAIP3 gene in COVID 19 patients
G-1082A IL-10 gene polymorphism does not impact COVID 19 infection risk
Impact of the G-308A TNFA gene SNP on development of COVID 19 infection
Sunday 2 Jun
Development of an in vitro method to differentiate hematopoietic stem cells into microglial-like cells
Challenge accepted: Results from the pivotal Grass Phase III clinical trial
Q&A session
Successes and challenges of Immunotherapy
×